Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: PBMs next in Senate committee’s crosshairs; lawmakers continue scrutiny on insulin prices; bill introduction suspending medical device tax delayed; Grassley renews nursing home abuse inquiry; more committees hold more drug pricing hearings; and more.… Continue Reading
Amid finger-pointing but few real fireworks, the seven pharmaceutical executives testifying before the Senate Finance Committee today offered lawmakers a spirited defense of the industry but also substantive policy concessions to address drug prices. They avoided gaffes and left the industry in no worse a political position than before the hearing. Democrats predictably were unsatisfied, … Continue Reading
Below is the Federal Policy team’s weekly preview, published each week when Congress is in session. HEADLINES • Furloughed federal employees are returning to work for at least three weeks after President Trump signed a short-term funding bill to allow lawmakers time to negotiate on an immigration and border security package. • A Chinese delegation … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: With the shutdown over (for now), the FDA is back in business; two hearings spotlight drug prices; House GOP questions CMS on Medicaid managed care; and more.… Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. We’re posting on Tuesday this week because of the Martin Luther King, Jr. federal holiday. Highlights this week: Gottlieb warns FDA’s funds running low as shutdown continues; House Dems launch sweeping probe on drug prices, Senate approves … Continue Reading